(Q35803924)

10 August 2017

Interaction between saquinavir soft-gel and rifabutin in patients infected with HIV (English)

1 reference

10 August 2017

1 reference

1 reference

G J Moyle

1

1 reference

10 August 2017

N E Buss

2

1 reference

10 August 2017

T Goggin

3

1 reference

10 August 2017

P Snell

4

1 reference

10 August 2017

C Higgs

5

1 reference

10 August 2017

D A Hawkins

6

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

54

1 reference

10 August 2017

2

1 reference

10 August 2017

178-182

1 reference

P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Mycobacterium avium complex infection in the acquired immunodeficiency syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

A pharmacokinetic study of intermittent rifabutin dosing with a combination of ritonavir and saquinavir in patients infected with human immunodeficiency virus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patients.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874397

Ritonavir enables combined therapy with rifampin and saquinavir

25 September 2018

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

1 reference

12 December 2020

Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasma

1 reference

12 December 2020

Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy

1 reference

12 December 2020

[Anterior uveitis in HIV-infected patients. 3 cases in patients treated with an antiprotease]

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01631.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

12207638

1 reference